XtalPi Holdings company profile

2228 · HKEX · HKD

Compare XtalPi Holdings
$4.80Change from previous close: −8.22%Absolute change: −$0.43

Close · November 20, 2026

Company profile

XtalPi Holdings has 1,623 employees and is headquartered in Shenzhen, China.

XtalPi Holdings Limited operates a research platform in Mainland China, the United States and other markets. Its offerings include XmartChem, an intelligent synthesis workstation that automates chemical synthesis, PatSight, a tool that extracts chemical structures from patents, and XMolGen, a generative chemistry tool. It also provides drug discovery solutions, from hit discovery to lead optimization, and peptide design through PepiX. Partners include Pfizer, with which it co-builds an AI-driven molecular simulation platform, and DoveTree, for therapeutics targeting difficult-to-drug targets. Formerly QuantumPharm Inc., it adopted its current name in December 2024.

With 1,623 employees, the company reported revenue of CNY 802.6 million and net income of CNY 123.7 million in the fiscal year ended December 2025. It was founded in 2015 and is headquartered in Shenzhen, China.

Company facts

Industry
Health Information Services
Headquarters
Second Phase of the International, Shenzhen
Employees
1,623
Chief executive
Jian Ma
Founded
2015
Fiscal year
January - December
Listing
2228 · HKEX
Currency
HKD
ISIN
KYG7S12M1051
Website
xtalpi.com

XtalPi Holdings and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
XtalPi Holdings2228Hong Kong SAR China$3B1,623-124.6%—
M32413Japan$7.04B17,01019.5%24.4
4DMedical4DXAustralia$867.27M181-813.7%—
Pro MedicusPMEAustralia$13.08B15374.9%76.0
DoximityDOCSUnited States$5.13B88027.1%39.9
Tempus AITEMUnited States$9.86B3,800-18.5%—

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare XtalPi Holdings with its competitors